Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover a cost-effective, high-yield synthesis of tolvaptan intermediate with no special equipment or toxic reagents. Reduce production risks and costs for your API manufacturing.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Solve supply chain risks for (2S,4R)-2-amino-4-methylnonanoic acid with this 8-step, high-yield synthesis. Achieve >99% optical purity at scale. Contact us for CDMO solutions.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.
Solve low-yield indolopyrrolone synthesis challenges with rhenium-catalyzed C-H activation. Achieve 95%+ yields, broad substrate tolerance, and scalable production for your drug development.
Solve supply chain risks with this novel 2-chlorothiophene-5-formic acid synthesis. 99.8% purity, 82% yield, and minimal waste. Ideal for rivaroxaban API production.
Solve high-cost, low-yield issues in salicylic acid synthesis. Our CDMO expertise enables scalable, eco-friendly production with >90% yield and minimal purification steps.
Discover cost-effective 1H-indole-2-amide production using cobalt-catalyzed C-H activation. Reduce supply chain risks and 30% production costs vs noble metal methods for API synthesis.
Solve azacyclooctanofuranone synthesis challenges with iron-catalyzed one-pot method. Reduce costs, improve yield, and ensure green production for pharma R&D and procurement teams.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.
Discover how axial chiral bisindole catalysts with >95:5 er enable scalable asymmetric synthesis, reducing R&D costs and supply chain risks for pharmaceutical intermediates.
Overcome high costs and safety risks in 2-chloro-4-fluorobenzoic acid production. Our new Meerwein arylation method eliminates noble metals, reduces waste, and achieves >80% yield for saflufenacil synthesis.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral chroman-4-ones for anticancer drug development. Reduce supply chain risks and improve purity.
Solve imidazo[1,2-a]pyridine amine synthesis challenges with 90%+ yields. Reduce steps, costs, and supply chain risks. Contact for CDMO solutions.
Solve high-cost chiral synthesis challenges with this patent-validated method. Achieve >70% ee and 92% yield in mild conditions. Contact us for GMP-compliant production.
Solve low yield and toxic reagent issues in zafirlukast intermediate production. 91.6% yield, eco-friendly process, and scalable CDMO solutions for pharma R&D and procurement.